Interferon gene expression declines over time post-COVID infection and in long COVID patients

A. Gómez-Carballa S. Pischedda J. Pardo-Seco J. Gómez-Rial F. Martinón-Torres A. Salas a Genetics,Vaccines and Infections Research Group (GENVIP),Instituto de Investigación Sanitaria de Santiago,Universidade de Santiago de Compostela,Santiago de Compostela,Galicia,Spainb Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES),Madrid,Spainc Unidade de Xenética,Instituto de Ciencias Forenses,Facultade de Medicina,Universidade de Santiago de Compostela,and GenPoB Research Group,Instituto de Investigación Sanitaria (IDIS),Hospital Clínico Universitario de Santiago de Compostela (SERGAS),Santiago de Compostela,Galicia,Spaind TranslationalPediatrics and Infectious Diseases,Department of Pediatrics,Hospital Clínico Universitario de Santiago de Compostela (SERGAS),Santiago de Compostela,Galicia,Spaine Servicio de Inmunología,Hospital Clínico Universitario Santiago de Compostela,Santiago de Compostela,Galicia,Spain
DOI: https://doi.org/10.1080/23744235.2024.2389481
2024-08-22
Infectious Diseases
Abstract:Background Interferons (IFNs) represent a first-line defense against viruses and other pathogens. It has been shown that an impaired and uncontrolled release of these glycoproteins can result in tissue damage and explain severe progression of coronavirus disease 2019 (COVID-19). However, their potential role in Long-COVID syndrome (LC) remains debateable.
infectious diseases
What problem does this paper attempt to address?